An interventional study of AI-enabled ECG-based Screening Tool in Hyperthyroidism, sponsored by National Defense Medical Center, Taiwan. Active, not recruiting at 1 site in Taiwan. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2023-03-23.
Sponsored by National Defense Medical Center, Taiwan · Not applicable, Interventional, and Screening
hyperthyroidism
111 studies on the registry are indexed under Hyperthyroidism; 28 are open to participants now.
This study's planned enrollment of 35,000 is above the median of 60 across 54 interventional studies indexed under Hyperthyroidism.
Browse Hyperthyroidism studies →National Defense Medical Center, Taiwan is the lead sponsor of 63 studies on the registry; 17 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
Patients randomized to intervention will have access to the screening tool
Other: AI-enabled ECG-based Screening Tool
Patients randomized to control will continue routine practice.
Primary care clinicians in the intervention group had access to the report, which displayed whether the AI-ECG result was positive or negative. The system will send a message to corresponding physicians if positive finding.
New-onset hyperthyroidism
A TSH of \<0.25 IU/L
Time frame: Within 30 days
New-onset anti-throid drug treatment
New anti-throid drug treatment for patients with subclinical hyperthyroidism
Time frame: Within 60 days
All-cause mortality
All-cause mortality
Time frame: Within 1 year.
Cardiac event
Heart failure, arrhythmia, etc.
Time frame: Within 1 year.
Plan to share: No
No publications or documents are linked to this record.
This study is active, not recruiting, as verified in Mar 2023. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
National Defense Medical Center, Taiwan